Hawton A, Goodwin E, Boddy K, Freeman J, et al. Measuring the cost-effectiveness of treatments for people with multiple sclerosis: Beyond quality-adjusted life-years. Mult Scler 2020 Sep 3:1352458520954172. doi: 10.1177/1352458520954172.
PMID: 32880511